Wearable Ocular Feedback for Real-Time Drug Dosing Evaluation

The patent implements real-time feedback loops where ocular biomarkers are continuously monitored during drug administration. The system provides immediate feedback on drug effectiveness through eye movement and pupil response measurements, eliminating the need for prolonged trial-and-error periods. This closed-loop feedback mechanism allows clinicians to adjust dosage based on real-time physiological responses rather than waiting for long-term outcome assessment.

The patent replaces the mechanical trial-and-error process with an automated optical measurement system. Instead of manually observing and interpreting patient responses over time, the system uses cameras and image processing algorithms to automatically quantify ocular biomarkers. This substitution of mechanical observation with automated optical sensing dramatically reduces the time required to evaluate drug effectiveness.

The patent transforms subjective mental state assessment into objective quantitative parameters by measuring ocular biomarkers such as pupil diameter, eye movement velocity, and blink frequency. These physical parameters provide precise, measurable indicators of mental condition that complement clinical judgment. The system captures multiple ocular parameters simultaneously, enabling comprehensive evaluation of drug effects on different aspects of mental function.

The patent introduces ocular biomarkers as intermediary measurements between drug administration and mental state assessment. Rather than directly observing complex mental processes, the system measures intermediate ocular responses that are physiologically linked to central nervous system activity. These ocular intermediaries provide accessible, quantifiable proxies for evaluating drug effects on mental conditions.

The patent creates a multi-functional integrated system that combines ocular imaging, biomarker extraction, population database comparison, and AI-based treatment recommendation in a single platform. The same hardware infrastructure supports multiple functions including real-time monitoring, historical data analysis, and predictive modeling. This universal system approach manages complexity by consolidating multiple functions into unified software modules rather than separate systems.

The patent implements self-service capabilities where the system automatically performs data normalization, bias correction, and treatment recommendation generation without requiring manual intervention. The AI algorithms autonomously compare individual patient responses against population databases and adjust for demographic variables. This automation reduces operational complexity by eliminating manual data processing steps while maintaining high reliability through consistent algorithmic application.